The role of microglial activation in disease progression

Multiple Sclerosis

Volumn 20, Issue 10, 2014, Pages 1288-1295

  Correale, Jorge ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

Author keywords

Autoimmunity; Axon; Microglia; Multiple sclerosis; Progressive multiple sclerosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPA RECEPTOR; CANNABINOID 1 RECEPTOR; CD200 ANTIGEN; CD200 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE;

AGING; BRAIN CORTEX LESION; BRAIN DEVELOPMENT; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INTRACELLULAR SIGNALING; MICROGLIAL ACTIVATION; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NERVE CELL CHARACTERISTICS AND FUNCTIONS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SYNAPTIC TRANSMISSION; AGE; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MICROGLIA; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; CYTOKINES; DISEASE PROGRESSION; HUMANS; INFLAMMATION MEDIATORS; MICROGLIA; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84908463311     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514533230     Document Type: Review

References (60)

1. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brain. Brain 2009; 132: 1175-1189.
2. Meuth SG, Simon OJ, Grimm A, et al. CNS inflammation and neuronal degeneration is aggravated in impaired CD200-CD200R-mediated macrophage silencing. J Neuroimmunol 2008; 194: 62-69.
3. Kassmann CM, Lappe-Siefke C, Baes M, et al. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 2007; 39: 969-976.
4. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010; 330: 841-845.
5. Ajami B, Bennet JL, Krieger C, et al. Local selfrenewal can sustain CNS microglial maintenance and function throughout adult life. Nat Neurosci 2007; 10: 1538-1543.
6. Soulas C, Donahue RE, Dunbar CE, et al. Genetically modified CD34+ hematopoietic stem cells contribute to turnover of brain perivascular macrophages in long-term repopulated primates. Am J Pathol 2009; 174: 1808-1817.
7. Czeh M, Gressens P and Kaindl AM. The yin and yang of microglia. Dev Neurosci 2011; 33: 199-201.
8. Beanrroch EE. Microglia. Multiple roles in surveillance, circuit shaping and response injury. Neurology 2013; 81: 1079-1088.
9. Perry VH, Nicoll JAR and Holmes C. Microglia in neurodegenerative diseases. Nat Rev Neurol 2010; 6: 193-201.
10. Hanisch UK and Ketenmann H. Microglia: Active sensor and versatile effector cells in the normal and pathological brain. Nat Neurosci 2007; 10: 1387-1394.
11. Ransohoff RM and Cadorna AE. The myeloid cells of the central nervous parenchyma. Nature 2010; 468; 253-262.
12. Geissmann F, Gorodn S, Hume DA, et al. Unravelling mononuclear phagocyte heterogeneity. Nat Rev Immunol 2010; 10: 453-460.
13. Mosser DM and Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
14. Chakraborty S, Kaushik DK, Gupta M, et al. Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res 2010; 88: 1615-1631.
15. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPS cause inflammatory response to injury. Nature 2010; 464: 104-107.
16. Harris RA and Amor S. Sweet and sour-oxidative and carbonyl stress in neurological disorders. CNS Neurol Disord Drug Targets 2011; 10: 82-107.
17. Zabel MK and Kirsch WM. From development to dysfunction: Microglia and the complement cascade in CNS homeostasis. Ageing Res Rev 2013; 12: 749-756.
18. Kettenmann H, Hanisch UK, Noda M, et al. Physiology of microglia. Physiol Rev 2011; 91: 461-553.
19. Barclay AN, Wright GJ, Brooke G, et al. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 2002; 23: 285-290.
20. Oldenborg PA, Greshan ID and Lindberg FP. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fc gamma and complement receptor-mediated phagocytosis. J Exp Med 2001; 193: 855-862.
21. Hatori K, Nagai A, Heisel R, et al. Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 2002; 69: 418-426.
22. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
23. Medana I, Martinic MA, Wekerle H, et al. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 2001; 159: 809-815.
24. Mathey EK, Derfuss T, Storch MK, et al. Neurofascin as a novel target for autoantibody-mediated injury. J Exp Med 2007; 204: 2363-2372.
25. Derfuss T, Parikh K, Velhin S, et al. Contactin 2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc Natl Acad Sci U S A 2009; 106: 8302-8307.
26. Lassmann H. Mechanisms of white matter damage in multiple sclerosis. Glia. Epub ahead of print 28 January 2014. DOI: 10.1002/glia.22597.
27. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712.
28. De Groot CJ, Bergers E, Kamphorst W, et al. Postmortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain 2001; 124 (Pt 8): 1635-1645.
29. Wong WT. Microglial aging in the healthy CNS: Phenotype, drivers and rejuvenation. Front Cell Neurosci 2013; 7: 22.
30. Lisak RP, Benjamins JA, Bealmer B, et al. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. J Neuroinflammation 2009; 6: 4
31. Campbell GR, Ziabreva I, Reeve AK, et al. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 2010; 69: 481-492.
32. Lassmann H and van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 2011; 585: 3715-3723.
33. Mahad DJ, Ziabreva I, Campbell G, et al. Mitochondrial changes within axons in multiple sclerosis. Brain 2009; 132 (Pt 5): 1161-1174.
34. Fischer MT, Sharma R, Lim JL, et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 2012; 135: 886-889.
35. Bolaños JP, Almeida A, Stewart V, et al. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases. J Neurochem 1997; 68: 2227-2240.
36. Smith JJ and Lasmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002; 1: 232-241.
37. Lu F, Selak M, O'Connor J, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000; 177: 95-103.
38. Balaban RS, Nemoto S and Finkel T. Mitochondria, oxidants and ageing. Cell 2005; 120: 483-495.
39. Love S. Oxidative stress in brain ischemia. Brain Pathol 1999; 9: 119-131.
40. Zeis T, Propst A, Steck AJ, et al. Molecular changes in white matter adjacent to an active demyelination lesion in early multiple sclerosis. Brain Pathol 2009; 19: 459-466.
41. Chéret C, Gervais A, Lelli A, et al. Neurotoxic activation of microglial is promoted by a nox1-dependent NADPH oxidase. Neurobiol Dis 2008; 28: 12039-12051.
42. Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci 2005; 133: 3-13.
43. Jomova K and Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011; 283: 65-87.
44. Hametner S, Wimmer I, Haider L, et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013; 74: 848-861.
45. Sharma R, Frischer MT, Bauer J, et al. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol 2010; 120: 223-236.
46. Marignier R, Nicolle A, Watrin C, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain 2010; 133: 2578-2591.
47. Fünfschilling U, Supplie LM, Mahad D, et al. Glycolitic oligodendrocytes maintain myelin and longterm axonal integrity. Nature 2012; 485: 517-521.
48. Starossom SC, Mascanfroni ID, Imitola J, et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012; 37: 249-263.
49. Popescu BFG and Luccinetti CF. Meningeal and cortical grey matter pathology in multiple sclerosis. BMC Neurology 2012; 12: 11
50. Lucchinettia CF, Popescu BFG, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365: 2188-2197.
51. Bö L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex in multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62; 723-732.
52. Fischer MT, Wimmer I, Höftberger R, et al. Diseasespecific molecular events in cortical multiple sclerosis. Brain 2013; 136: 1799-1815.
53. Serafini B, Rosicarelli B, Magiozzi R, et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004; 14: 164-174.
54. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011; 134: 2755-2771.
55. Confavreaux C and Vukusic S. Natural history of multiple sclerosis: A unifying concept. Brain 2006; 129: 606-616.
56. Laird MD, Shields JS, Sukumari-Ramesh S, et al. High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 2014; 62: 26-38.
57. Kettenmann H, Kirchhoff F and Verkhratsky A. Microglia: New roles for the synaptic stripper. Neuron 2013; 77: 10-18.
58. Centonze D, Muzio L, Russi S, et al. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ 2010; 17: 1083-1091.
59. Cetonze D, Bari M, Rossi S, et al. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 2007; 130: 2543-2553.
60. Cetonze D, Muzio L, Rossi S, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009; 29: 3442-3452.